Blazar BR - Search Results

1

Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging.

Min D, Panoskaltsis-Mortari A, Kuro-O M, Holländer GA, Blazar BR, Weinberg KI. Min D, et al. Among authors: blazar br. Blood. 2007 Mar 15;109(6):2529-37. doi: 10.1182/blood-2006-08-043794. Epub 2006 Nov 30. Blood. 2007. PMID: 17138819 Free PMC article.

2

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha.

Blazar BR, Widmer MB, Taylor PA, Vallera DA. Blazar BR, et al. Blood. 1992 Sep 15;80(6):1614-22. Blood. 1992. PMID: 1369829 Free article.

3

Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor.

Blazar BR, Widmer MB, Soderling CC, Urdal DL, Gillis S, Robison LL, Vallera DA. Blazar BR, et al. Blood. 1988 Feb;71(2):320-8. Blood. 1988. PMID: 3276361 Free article.

4

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.

Vallera DA, Taylor PA, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Among authors: blazar br. Blood. 1995 Dec 1;86(11):4367-75. Blood. 1995. PMID: 7492798 Free article.

5

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Blazar BR, et al. Blood. 1995 May 1;85(9):2607-18. Blood. 1995. PMID: 7537122 Free article.

6

Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.

Blazar BR, Taylor PA, Smith S, Vallera DA. Blazar BR, et al. Blood. 1995 Feb 1;85(3):842-51. Blood. 1995. PMID: 7833486 Free article.

7

Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice.

Vallera DA, Taylor PA, Vannice JL, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Among authors: blazar br. Transplantation. 1995 Dec 15;60(11):1371-4. Transplantation. 1995. PMID: 8525541

8

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Barrett TA, Bluestone JA, Vallera DA. Blazar BR, et al. Blood. 1996 Jan 15;87(2):827-37. Blood. 1996. PMID: 8555509 Free article.

9

Lack of GVHD across classical, single minor histocompatibiliTy (miH) locus barriers in mice.

Blazar BR, Roopenian DC, Taylor PA, Christianson GJ, Panoskaltsis-Mortari A, Vallera DA. Blazar BR, et al. Transplantation. 1996 Feb 27;61(4):619-24. doi: 10.1097/00007890-199602270-00017. Transplantation. 1996. PMID: 8610390

10

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sehgal S, Vallera DA. Blazar BR, et al. Blood. 1996 May 1;87(9):4001-9. Blood. 1996. PMID: 8611733 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

905 results

Search Page

Filters